世界の急性激越・攻撃性治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Acute Agitation and Aggression Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A13967 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、急性激越・攻撃性治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。急性激越・攻撃性治療の種類別市場規模（経口、筋肉内注射、その他）、用途別市場規模（病院・外来手術センター、精神科医療施設、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・急性激越・攻撃性治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eli Lilly and Company、Pfizer、Ono Pharmaceutical、Otsuka Holdings、GlaxoSmithKline、Bristol-Myers Squibb、Johnson & Johnson、H. Lundbeck A/S ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経口、筋肉内注射、その他 ・用途別分析2016年-2026年：病院・外来手術センター、精神科医療施設、その他 ・急性激越・攻撃性治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・急性激越・攻撃性治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・急性激越・攻撃性治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・急性激越・攻撃性治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・急性激越・攻撃性治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Acute Agitation and Aggression Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Acute Agitation and Aggression Treatment size is estimated to be USD 2872.4 million in 2026 from USD 2584.1 million in 2020, with a change XX% between 2020 and 2021. The global Acute Agitation and Aggression Treatment market size is expected to grow at a CAGR of 2.7% for the next five years.

Market segmentation
Acute Agitation and Aggression Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Oral
Intramuscular Injection
Others

Market segment by Application, can be divided into
Hospitals & Ambulatory Surgical Centers
Psychiatric Care Facilities
Others

Market segment by players, this report covers
Eli Lilly and Company
Pfizer
Ono Pharmaceutical
Otsuka Holdings
GlaxoSmithKline
Bristol-Myers Squibb
Johnson & Johnson
H. Lundbeck A/S

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Acute Agitation and Aggression Treatment
1.2 Classification of Acute Agitation and Aggression Treatment by Type
1.2.1 Overview: Global Acute Agitation and Aggression Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Acute Agitation and Aggression Treatment Revenue Market Share by Type in 2020
1.2.3 Oral
1.2.4 Intramuscular Injection
1.2.5 Others
1.3 Global Acute Agitation and Aggression Treatment Market by Application
1.3.1 Overview: Global Acute Agitation and Aggression Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals & Ambulatory Surgical Centers
1.3.3 Psychiatric Care Facilities
1.3.4 Others
1.4 Global Acute Agitation and Aggression Treatment Market Size & Forecast
1.5 Global Acute Agitation and Aggression Treatment Market Size and Forecast by Region
1.5.1 Global Acute Agitation and Aggression Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Acute Agitation and Aggression Treatment Market Size by Region, (2016-2021)
1.5.3 North America Acute Agitation and Aggression Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Acute Agitation and Aggression Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Acute Agitation and Aggression Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Acute Agitation and Aggression Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Acute Agitation and Aggression Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Acute Agitation and Aggression Treatment Market Drivers
1.6.2 Acute Agitation and Aggression Treatment Market Restraints
1.6.3 Acute Agitation and Aggression Treatment Trends Analysis
2 Company Profiles
2.1 Eli Lilly and Company
2.1.1 Eli Lilly and Company Details
2.1.2 Eli Lilly and Company Major Business
2.1.3 Eli Lilly and Company Acute Agitation and Aggression Treatment Product and Solutions
2.1.4 Eli Lilly and Company Acute Agitation and Aggression Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Eli Lilly and Company Recent Developments and Future Plans
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Acute Agitation and Aggression Treatment Product and Solutions
2.2.4 Pfizer Acute Agitation and Aggression Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Pfizer Recent Developments and Future Plans
2.3 Ono Pharmaceutical
2.3.1 Ono Pharmaceutical Details
2.3.2 Ono Pharmaceutical Major Business
2.3.3 Ono Pharmaceutical Acute Agitation and Aggression Treatment Product and Solutions
2.3.4 Ono Pharmaceutical Acute Agitation and Aggression Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Ono Pharmaceutical Recent Developments and Future Plans
2.4 Otsuka Holdings
2.4.1 Otsuka Holdings Details
2.4.2 Otsuka Holdings Major Business
2.4.3 Otsuka Holdings Acute Agitation and Aggression Treatment Product and Solutions
2.4.4 Otsuka Holdings Acute Agitation and Aggression Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Otsuka Holdings Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Acute Agitation and Aggression Treatment Product and Solutions
2.5.4 GlaxoSmithKline Acute Agitation and Aggression Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Bristol-Myers Squibb
2.6.1 Bristol-Myers Squibb Details
2.6.2 Bristol-Myers Squibb Major Business
2.6.3 Bristol-Myers Squibb Acute Agitation and Aggression Treatment Product and Solutions
2.6.4 Bristol-Myers Squibb Acute Agitation and Aggression Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Acute Agitation and Aggression Treatment Product and Solutions
2.7.4 Johnson & Johnson Acute Agitation and Aggression Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 H. Lundbeck A/S
2.8.1 H. Lundbeck A/S Details
2.8.2 H. Lundbeck A/S Major Business
2.8.3 H. Lundbeck A/S Acute Agitation and Aggression Treatment Product and Solutions
2.8.4 H. Lundbeck A/S Acute Agitation and Aggression Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 H. Lundbeck A/S Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Acute Agitation and Aggression Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Acute Agitation and Aggression Treatment Players Market Share
3.2.2 Top 10 Acute Agitation and Aggression Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Acute Agitation and Aggression Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Acute Agitation and Aggression Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Acute Agitation and Aggression Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Acute Agitation and Aggression Treatment Revenue Market Share by Application (2016-2021)
5.2 Acute Agitation and Aggression Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Acute Agitation and Aggression Treatment Revenue by Type (2016-2026)
6.2 North America Acute Agitation and Aggression Treatment Revenue by Application (2016-2026)
6.3 North America Acute Agitation and Aggression Treatment Market Size by Country
6.3.1 North America Acute Agitation and Aggression Treatment Revenue by Country (2016-2026)
6.3.2 United States Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Acute Agitation and Aggression Treatment Revenue by Type (2016-2026)
7.2 Europe Acute Agitation and Aggression Treatment Revenue by Application (2016-2026)
7.3 Europe Acute Agitation and Aggression Treatment Market Size by Country
7.3.1 Europe Acute Agitation and Aggression Treatment Revenue by Country (2016-2026)
7.3.2 Germany Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
7.3.3 France Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Acute Agitation and Aggression Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Acute Agitation and Aggression Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Acute Agitation and Aggression Treatment Market Size by Region
8.3.1 Asia-Pacific Acute Agitation and Aggression Treatment Revenue by Region (2016-2026)
8.3.2 China Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
8.3.5 India Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Acute Agitation and Aggression Treatment Revenue by Type (2016-2026)
9.2 South America Acute Agitation and Aggression Treatment Revenue by Application (2016-2026)
9.3 South America Acute Agitation and Aggression Treatment Market Size by Country
9.3.1 South America Acute Agitation and Aggression Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Acute Agitation and Aggression Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Acute Agitation and Aggression Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Acute Agitation and Aggression Treatment Market Size by Country
10.3.1 Middle East & Africa Acute Agitation and Aggression Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Acute Agitation and Aggression Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Acute Agitation and Aggression Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Acute Agitation and Aggression Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Acute Agitation and Aggression Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Acute Agitation and Aggression Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Acute Agitation and Aggression Treatment Revenue Market Share by Region (2021-2026)
Table 6. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors
Table 7. Eli Lilly and Company Major Business
Table 8. Eli Lilly and Company Acute Agitation and Aggression Treatment Product and Solutions
Table 9. Eli Lilly and Company Acute Agitation and Aggression Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Pfizer Corporate Information, Head Office, and Major Competitors
Table 11. Pfizer Major Business
Table 12. Pfizer Acute Agitation and Aggression Treatment Product and Solutions
Table 13. Pfizer Acute Agitation and Aggression Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Ono Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 15. Ono Pharmaceutical Major Business
Table 16. Ono Pharmaceutical Acute Agitation and Aggression Treatment Product and Solutions
Table 17. Ono Pharmaceutical Acute Agitation and Aggression Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Otsuka Holdings Corporate Information, Head Office, and Major Competitors
Table 19. Otsuka Holdings Major Business
Table 20. Otsuka Holdings Acute Agitation and Aggression Treatment Product and Solutions
Table 21. Otsuka Holdings Acute Agitation and Aggression Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Major Business
Table 24. GlaxoSmithKline Acute Agitation and Aggression Treatment Product and Solutions
Table 25. GlaxoSmithKline Acute Agitation and Aggression Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 27. Bristol-Myers Squibb Major Business
Table 28. Bristol-Myers Squibb Acute Agitation and Aggression Treatment Product and Solutions
Table 29. Bristol-Myers Squibb Acute Agitation and Aggression Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Acute Agitation and Aggression Treatment Product and Solutions
Table 33. Johnson & Johnson Acute Agitation and Aggression Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. H. Lundbeck A/S Corporate Information, Head Office, and Major Competitors
Table 35. H. Lundbeck A/S Major Business
Table 36. H. Lundbeck A/S Acute Agitation and Aggression Treatment Product and Solutions
Table 37. H. Lundbeck A/S Acute Agitation and Aggression Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Acute Agitation and Aggression Treatment Revenue (USD Million) by Players (2019-2021)
Table 39. Global Acute Agitation and Aggression Treatment Revenue Share by Players (2019-2021)
Table 40. Breakdown of Acute Agitation and Aggression Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Acute Agitation and Aggression Treatment Players Head Office, Products and Services Provided
Table 42. Acute Agitation and Aggression Treatment Mergers & Acquisitions in the Past Five Years
Table 43. Acute Agitation and Aggression Treatment New Entrants and Expansion Plans
Table 44. Global Acute Agitation and Aggression Treatment Revenue (USD Million) by Type (2016-2021)
Table 45. Global Acute Agitation and Aggression Treatment Revenue Share by Type (2016-2021)
Table 46. Global Acute Agitation and Aggression Treatment Revenue Forecast by Type (2021-2026)
Table 47. Global Acute Agitation and Aggression Treatment Revenue by Application (2016-2021)
Table 48. Global Acute Agitation and Aggression Treatment Revenue Forecast by Application (2021-2026)
Table 49. North America Acute Agitation and Aggression Treatment Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Acute Agitation and Aggression Treatment Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Acute Agitation and Aggression Treatment Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Acute Agitation and Aggression Treatment Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Acute Agitation and Aggression Treatment Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Acute Agitation and Aggression Treatment Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Acute Agitation and Aggression Treatment Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Acute Agitation and Aggression Treatment Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Acute Agitation and Aggression Treatment Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Acute Agitation and Aggression Treatment Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Acute Agitation and Aggression Treatment Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Acute Agitation and Aggression Treatment Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Acute Agitation and Aggression Treatment Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Acute Agitation and Aggression Treatment Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Acute Agitation and Aggression Treatment Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Acute Agitation and Aggression Treatment Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Acute Agitation and Aggression Treatment Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Acute Agitation and Aggression Treatment Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Acute Agitation and Aggression Treatment Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Acute Agitation and Aggression Treatment Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Acute Agitation and Aggression Treatment Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Acute Agitation and Aggression Treatment Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Acute Agitation and Aggression Treatment Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Acute Agitation and Aggression Treatment Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Acute Agitation and Aggression Treatment Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Acute Agitation and Aggression Treatment Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Acute Agitation and Aggression Treatment Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Acute Agitation and Aggression Treatment Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Acute Agitation and Aggression Treatment Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Acute Agitation and Aggression Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Acute Agitation and Aggression Treatment Picture
Figure 2. Global Acute Agitation and Aggression Treatment Revenue Market Share by Type in 2020
Figure 3. Oral
Figure 4. Intramuscular Injection
Figure 5. Others
Figure 6. Acute Agitation and Aggression Treatment Revenue Market Share by Application in 2020
Figure 7. Hospitals & Ambulatory Surgical Centers Picture
Figure 8. Psychiatric Care Facilities Picture
Figure 9. Others Picture
Figure 10. Global Acute Agitation and Aggression Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Acute Agitation and Aggression Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Acute Agitation and Aggression Treatment Revenue Market Share by Region (2016-2026)
Figure 13. Global Acute Agitation and Aggression Treatment Revenue Market Share by Region in 2020
Figure 14. North America Acute Agitation and Aggression Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Acute Agitation and Aggression Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Acute Agitation and Aggression Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Acute Agitation and Aggression Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Acute Agitation and Aggression Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Acute Agitation and Aggression Treatment Market Drivers
Figure 20. Acute Agitation and Aggression Treatment Market Restraints
Figure 21. Acute Agitation and Aggression Treatment Market Trends
Figure 22. Eli Lilly and Company Recent Developments and Future Plans
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Ono Pharmaceutical Recent Developments and Future Plans
Figure 25. Otsuka Holdings Recent Developments and Future Plans
Figure 26. GlaxoSmithKline Recent Developments and Future Plans
Figure 27. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 28. Johnson & Johnson Recent Developments and Future Plans
Figure 29. H. Lundbeck A/S Recent Developments and Future Plans
Figure 30. Global Acute Agitation and Aggression Treatment Revenue Share by Players in 2020
Figure 31. Acute Agitation and Aggression Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Acute Agitation and Aggression Treatment Revenue Market Share in 2020
Figure 33. Global Top 10 Players Acute Agitation and Aggression Treatment Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Acute Agitation and Aggression Treatment Revenue Share by Type in 2020
Figure 36. Global Acute Agitation and Aggression Treatment Market Share Forecast by Type (2021-2026)
Figure 37. Global Acute Agitation and Aggression Treatment Revenue Share by Application in 2020
Figure 38. Global Acute Agitation and Aggression Treatment Market Share Forecast by Application (2021-2026)
Figure 39. North America Acute Agitation and Aggression Treatment Sales Market Share by Type (2016-2026)
Figure 40. North America Acute Agitation and Aggression Treatment Sales Market Share by Application (2016-2026)
Figure 41. North America Acute Agitation and Aggression Treatment Revenue Market Share by Country (2016-2026)
Figure 42. United States Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Acute Agitation and Aggression Treatment Sales Market Share by Type (2016-2026)
Figure 46. Europe Acute Agitation and Aggression Treatment Sales Market Share by Application (2016-2026)
Figure 47. Europe Acute Agitation and Aggression Treatment Revenue Market Share by Country (2016-2026)
Figure 48. Germany Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Acute Agitation and Aggression Treatment Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Acute Agitation and Aggression Treatment Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Acute Agitation and Aggression Treatment Revenue Market Share by Region (2016-2026)
Figure 56. China Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Acute Agitation and Aggression Treatment Sales Market Share by Type (2016-2026)
Figure 63. South America Acute Agitation and Aggression Treatment Sales Market Share by Application (2016-2026)
Figure 64. South America Acute Agitation and Aggression Treatment Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Acute Agitation and Aggression Treatment Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Acute Agitation and Aggression Treatment Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Acute Agitation and Aggression Treatment Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Acute Agitation and Aggression Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source

---